Regentis Biomaterials Ltd. (RGNT)
NYSEAMERICAN: RGNT · Real-Time Price · USD
3.255
-0.105 (-3.12%)
Mar 9, 2026, 4:00 PM EDT - Market closed
Regentis Biomaterials Market Cap
Regentis Biomaterials has a market cap or net worth of $16.86 million as of March 9, 2026.
Market Cap
16.86M
Enterprise Value
10.68M
1-Year Change
n/a
Ranking
Category
Stock Price
$3.26
Market Cap Chart
Since the IPO on December 4, 2025, Regentis Biomaterials's market cap has decreased from $39.44M to $16.86M, a decrease of -57.25%. That is a compound annual growth rate of -96.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 17.40M | -50.15% |
| Dec 31, 2025 | 34.91M | -11.48% |
| Dec 4, 2025 | 39.44M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 900.85B |
| Johnson & Johnson | 584.62B |
| AbbVie | 402.17B |
| Novartis AG | 306.94B |
| Wellgistics Health | 17.53M |
| IN8bio | 17.29M |
| Serina Therapeutics | 17.15M |
| Reviva Pharmaceuticals Holdings | 16.83M |